CBA share price on watch following $5b cash profit and dividend boost

CBA's profits have come in slightly ahead of expectations.

| More on:
Happy man working on his laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Commonwealth Bank of Australia (ASX: CBA) share price will be on watch today.

That's because the banking giant has just released its half-year results and delivered a cash profit slightly ahead of expectations.

CBA share price on watch following half-year results

For the six months ended 31 December, Australia's largest bank reported the following compared to the prior corresponding period:

  • Operating income up 0.2% to $13,649 million
  • Operating expenses up 4% to $6,011 million
  • Cash net profit after tax down 3% to $5,019 million
  • Fully franked interim dividend up 2.4% to $2.15 per share

What happened during the half?

CBA's operating income was up slightly to $13,649 million during the first half. This was supported by volume growth and higher volume-based fee income, offset by margin compression.

Speaking of which, the bank's net interest margin has fallen 6 basis points since the end of FY 2023 to 1.99%. This reflects increased deposit price competition and deposit switching.

Also heading in the wrong direction were the bank's expenses. CBA's operating expenses increased 4% to $6,011 million due to inflationary pressures and additional spending on technology to support the delivery of strategic priorities.

This ultimately led to CBA's cash net profit after tax falling 3% to $5,019 million. Statutory net profit after tax was down by 8% to $4,837 million.

Nevertheless, this didn't stop the CBA board from lifting its fully franked interim dividend by 2.4% to $2.15 per share. This represents a payout ratio of 72%, which is up from 68% a year earlier.

CBA ended the period with a CET1 ratio of 12.3%.

How does this compare to expectations?

The good news for the CBA share price is that this result appears to have come in slightly ahead of expectations.

The market consensus estimate was for a first half cash profit of $4,972 million.

Outlook

CBA's CEO, Matt Comyn, commented that 2023 was a challenging year and warned that there could be some tough times ahead. He said:

2023 was increasingly challenging for many of our customers who are finding it harder to absorb cost of living pressures. The economy has been fairly resilient, supported by a strong labour market, savings and repayment buffers, population growth and relatively high commodity prices. However, downside risks are building as slowing demand and persistent inflation impact Australian businesses. Ongoing geopolitical tensions also create uncertainty.

As cash rate increases have a lagged impact on households and business customers, we expect financial strain to continue in 2024, with an uptick in our arrears and impairments. We remain well provisioned and capitalised, with capacity to navigate an uncertain economic environment.

The CBA share price is up 6% over the last 12 months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A senior investor wearing glasses sits at his desk and works on his ASX shares portfolio on his laptop2
Earnings Results

Dyno Nobel posts lower loss as transformation accelerates after fertilisers exit

Dyno Nobel trimmed its loss as underlying profit and dividends rose, with explosives now its sole focus after the fertilisers…

Read more »

Company's CEO at a meeting with workers talking about earnings results.
Earnings Results

ANZ Group Holdings' FY25 profit dips but dividend holds steady

ANZ Group Holdings’ FY25 profit fell but dividends remained steady, with underlying performance flat excluding significant items.

Read more »

A female financial services professional with a manicured black afro hairstyle turns an ipad screen to show a client across the table a set of ASX shares figures in graph format.
Earnings Results

Macquarie shares slump 7% on half-year earnings miss

Let's see how the investment bank performed during the first half.

Read more »

two men raise their fists and shout with their mouths wide open on a sofa as though they are watching sport or something stirring on a television that is out of picture.
Earnings Results

Nine Entertainment flags digital growth and more cost cuts in FY26 update

Nine Entertainment has reported upbeat digital subscription growth and expects further EBITDA gains, despite a tough ad market in FY26.

Read more »

A woman wearing a hat, sunglasses and a bathing suit reads the newspaper while sitting on a lounging chair that's placed in a pool in a relaxing setting.
Earnings Results

News Corporation Q1 FY26: Digital-led growth, higher buybacks

News Corporation lifted Q1 FY26 revenue and EBITDA, fuelled by digital growth and a strong performance from Dow Jones.

Read more »

A typical Australian family of mother, father, and two kids stands outside their modest but homely Australian suburban home complete with green grass, outdoor plants and furniture.
Earnings Results

REA Group share price on watch after Q1 FY26 results show growth in revenue and yield

REA Group delivered Q1 FY26 revenue growth and record audience, as its share price responds to the latest earnings results.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Earnings Results

Macquarie Group posts higher 1H26 profit and ups dividend

Macquarie Group delivered higher first-half profit and revenue, declared an interim dividend, and flagged cautious optimism amid mixed conditions.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Neuren Pharmaceuticals Q3 2025: Record DAYBUE sales fuel robust growth

Neuren Pharmaceuticals reported record DAYBUE sales and royalties in Q3 2025, with expanding US and international demand.

Read more »